Highlights • Cytokine storm is the outcome of respiratory illnesses such as MERS, SARS, and COVID-19. • Patients with cytokine storms exhibit mild to severe clinical manifestations. • Immune pathways such as JAK/STAT, mTOR, ERK, and TRAF/NF-κB are stimulated in respiratory illness. • Cytokine storm can be early controlled using immunomodulators and cytokine antagonists.
All Keywords
【저자키워드】 SARS-CoV-2, Cytokine storm, respiratory diseases, Biomarkers, and immune response,
【저자키워드】 SARS-CoV-2, Cytokine storm, respiratory diseases, Biomarkers, and immune response,